Nanoparticles in Melanoma

Author(s): M.A. Berciano-Guerrero, A. Montesa-Pino, G. Castaneda-Penalvo, L. Munoz-Fernandez, J. Rodriguez-Flores

Journal Name: Current Medicinal Chemistry

Volume 21 , Issue 32 , 2014

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Malignant melanoma is one of the most common causes of cancer and cancer deaths in young people. Until few years ago, scarce drugs have proven efficacy in metastatic setting. However, in the recent years, the treatment of metastatic malignant melanoma has undergone the incorporation of effective treatment such as immunotherapy, the use of tyrosine kinase inhibitors and the emergence of other cytostatic compounds, like the nanoparticles. This review aims to propose a standardization to classify the different types of nanoparticles, according to chemical aspects, and update the clinical research with nanoparticles and their use in melanoma field.

Keywords: Cancer, classification, melanoma, nab-paclitaxel, nanoparticles.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [3701 - 3716]
Pages: 16
DOI: 10.2174/0929867321666140716092512
Price: $65

Article Metrics

PDF: 35